184 related articles for article (PubMed ID: 16723247)
1. APT070 inhibits complement activation during in vitro cardiopulmonary bypass.
De Silva RJ; Vuylsteke A; Fritchley SJ; Trull AK; Dunning JJ; Wallwork J
Eur J Cardiothorac Surg; 2006 Jul; 30(1):72-6. PubMed ID: 16723247
[TBL] [Abstract][Full Text] [Related]
2. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil activation in paediatric extracorporeal circuits: effect of circulation and temperature variation.
el Habbal MH; Carter H; Smith LJ; Elliott MJ; Strobel S
Cardiovasc Res; 1995 Jan; 29(1):102-7. PubMed ID: 7534645
[TBL] [Abstract][Full Text] [Related]
4. Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass.
Lazar HL; Bokesch PM; van Lenta F; Fitzgerald C; Emmett C; Marsh HC; Ryan U;
Circulation; 2004 Sep; 110(11 Suppl 1):II274-9. PubMed ID: 15364875
[TBL] [Abstract][Full Text] [Related]
5. Inclusion of sevoflurane in cardioplegia reduces neutrophil activity during cardiopulmonary bypass.
Nader ND; Karamanoukian HL; Reedy RL; Salehpour F; Knight PR
J Cardiothorac Vasc Anesth; 2006 Feb; 20(1):57-62. PubMed ID: 16458215
[TBL] [Abstract][Full Text] [Related]
6. Activation of neutrophil granulocytes in an in vitro model of a cardiopulmonary bypass.
Asberg AE; Videm V
Artif Organs; 2005 Dec; 29(12):927-36. PubMed ID: 16305648
[TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
8. Conformational activation of CD11b without shedding of L-selectin on circulating human neutrophils.
Orr Y; Taylor JM; Cartland S; Bannon PG; Geczy C; Kritharides L
J Leukoc Biol; 2007 Nov; 82(5):1115-25. PubMed ID: 17675559
[TBL] [Abstract][Full Text] [Related]
9. Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass.
Banz Y; Rieben R; Zobrist C; Meier P; Shaw S; Lanz J; Carrel T; Berdat P
Eur J Cardiothorac Surg; 2008 Sep; 34(3):653-60. PubMed ID: 18572413
[TBL] [Abstract][Full Text] [Related]
10. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
[TBL] [Abstract][Full Text] [Related]
11. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass.
Ilmakunnas M; Pesonen EJ; Ahonen J; Rämö J; Siitonen S; Repo H
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):851-9. PubMed ID: 15821654
[TBL] [Abstract][Full Text] [Related]
12. Complement activation in prestorage leucocyte-filtered plasma.
Hyllner M; Tylman M; Bengtson JP; Rydberg L; Bengtsson A
Transfus Med; 2004 Feb; 14(1):45-52. PubMed ID: 15043593
[TBL] [Abstract][Full Text] [Related]
13. [Effect of complement 4 genetic polymorphism on complement activation during cardiopulmonary bypass in open heart surgery among children].
Zhang S; Li Q; Yao S
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):918-20. PubMed ID: 11702666
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylcholine coating of bypass systems used for young infants does not attenuate the inflammatory response.
Draaisma AM; Hazekamp MG; Anes N; Schoof PH; Hack CE; Sturk A; Dion RA
Ann Thorac Surg; 2006 Apr; 81(4):1455-9. PubMed ID: 16564292
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits.
Fung M; Loubser PG; Undar A; Mueller M; Sun C; Sun WN; Vaughn WK; Fraser CD
J Thorac Cardiovasc Surg; 2001 Jul; 122(1):113-22. PubMed ID: 11436043
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulation.
Rinder CS; Smith MJ; Rinder HM; Cortright DN; Brodbeck RM; Krause JE; Smith BR
Ann Thorac Surg; 2007 Jan; 83(1):146-52. PubMed ID: 17184649
[TBL] [Abstract][Full Text] [Related]
17. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil lactoferrin release during open heart surgery is unrelated to complement activation.
Shastri KA; Logue GL; Stern MP; Raza S; O'Connor BM; Bovill JJ; Hoover EL
ASAIO J; 1994; 40(1):56-61. PubMed ID: 8186493
[TBL] [Abstract][Full Text] [Related]
19. Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass.
Hadley JS; Wang JE; Michaels LC; Dempsey CM; Foster SJ; Thiemermann C; Hinds CJ
Shock; 2007 May; 27(5):466-73. PubMed ID: 17438450
[TBL] [Abstract][Full Text] [Related]
20. Effect of pericardial blood processing on postoperative inflammation and the complement pathways.
Marcheix B; Carrier M; Martel C; Cossette M; Pellerin M; Bouchard D; Perrault LP
Ann Thorac Surg; 2008 Feb; 85(2):530-5. PubMed ID: 18222258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
